sōlaria biō Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Sōlaria Biō operates in biotechnology research with a focus on the edible plant microbiome as a lever for human health. It translates microbial science discoveries into medical foods aimed at addressing fundamental biological drivers of disease. The lead product, Bōndia, is a plant-sourced synbiotic developed to preserve bone density via the gut–bone axis, and a randomized trial reported an 85% improvement in bone density in osteopenic women. Sōlaria Biō is building what it describes as the world’s largest library of plant-derived microbes to address underserved inflammatory conditions, from osteopenia to rheumatoid arthritis. The company is based in Waltham, Massachusetts, and operates as a clinical-stage biotechnology company developing food-derived microbial solutions for health. In October 2025, Catherine Balsam-Schwaber was appointed Chief Executive Officer to guide the next phase of the company’s growth.

Get verified sōlaria biō emails free

Company overview Employee directory